250
C.M. Reid et al. / Tetrahedron 71 (2015) 245e251
[
a
]
20 þ42.4 (c 1.0, CHCl3); dH (400 MHz, CDCl3) 1.44 (9H, s, tBu), 3.22
organic layers were concentrated in vacuo. To a solution of the
resulting residue (0.16 mmol) in dichloromethane (2 mL) was
added trifluoroacetic acid (0.80 mmol) and the reaction mixture
was stirred at room temperature under argon for 3 h. The reaction
mixture was concentrated in vacuo to give the TFA salts, which
were purified by recrystallisation from chloroform and methanol.
D
(1H, d, J 17.8 Hz, 3-HH), 3.41 (1H, d, J 17.8 Hz, 3-HH), 3.75 (3H, s,
OMe), 4.58e4.64 (1H, m, 2-H), 5.56 (1H, d, J 8.0 Hz, NH), 6.69 (1H, d,
J 16.0 Hz, 5-H), 7.40 (2H, d, J 8.0 Hz, ArH), 7.46e7.56 (3H, m, 6-H and
ArH); dC (101 MHz, CDCl3) 28.3 (3ꢂCH3), 42.6 (CH2), 49.6 (CH), 52.7
(CH3), 80.0 (C), 125.2 (C), 126.0 (CH), 129.8 (2ꢂCH), 132.3 (2ꢂCH),
133.0 (C), 142.5 (CH), 155.6 (C), 172.0 (C), 197.5 (C); m/z (FAB) 412
(MHþ, 22%), 358 (100), 356 (89), 314 (23), 278 (22), 234 (7); HRMS
(FAB): MHþ, found 412.0755. C18H2379BrNO5 requires 412.0760.
4.15.1. (2S,5E)-2-Amino-4-oxo-6-phenylhex-5-enoic
acid
tri-
fluoroacetate (18).21f Using the general procedure above gave
(2S,5E)-2-amino-4-oxo-6-phenylhex-5-enoic acid trifluoroacetate
(18) as a white solid (0.13 g, 95%). Mp 112e114 ꢁC (decomposition);
4.13. Methyl (2S,5E)-2-(tert-butoxycarbonylamino)-4-oxo-8-
phenyloct-5-enoate (16)21f
nmax (neat) 3028 (NH), 2914 (CH), 1738 (C]O), 1655 (C]C), 1495,
19
1184, 1134 cmꢀ1; [
a]
þ23.3 (c 1.0, MeOH); dH (400 MHz, CD3OD)
D
The reaction was performed as described above, using (2S)-2-
(tert-butoxycarbonylamino)-4-oxo-5-(trimethylsilanyl)pentanoate
(11) (0.80 g, 2.52 mmol) and 3-phenylpropionaldehyde (0.40 g,
3.0 mmol). Purification by flash chromatography (15% ethyl acetate
in petroleum ether) gave methyl (2S,5E)-2-(tert-butox-
ycarbonylamino)-4-oxo-8-phenyloct-5-enoate (16) as a colourless
oil (0.46 g, 53%). nmax (NaCl) 3439 (NH), 3371, 3027, 3004, 2978
3.43 (1H, dd, J 18.5, 6.1 Hz, 3-HH), 3.48e3.56 (1H, m, 3-HH),
4.22e4.28 (1H, m, 2-H), 6.92 (1H, d, J 16.2 Hz, 5-H), 7.40e7.48 (3H,
m, ArH), 7.62e7.69 (2H, m, ArH), 7.74 (1H, d, J 16.2 Hz, 6-H); dC
(101 MHz, CD3OD) 40.9 (CH2), 50.2 (CH), 126.1 (CH), 129.7 (2ꢂCH),
130.2 (2ꢂCH), 132.1 (CH), 135.6 (C), 146.0 (CH), 171.8 (C), 198.0 (C);
m/z (FAB) 220 (MHþ, 42%), 175 (7), 148 (16), 132 (12); HRMS (FAB):
MHþ, found 220.0973. C12H14NO3 requires 220.0974.
(CH), 2952, 2930, 2859, 1749 (C]O), 1714 (C]O), 1672, 1630, 1584
19
(C]C), 1497, 1367, 1167 cmꢀ1; [
a
]
þ47.4 (c 1.0, CHCl3); dH
4.15.2. (2S,5E)-2-Amino-6-(40-bromophenyl)-4-oxohex-5-enoic acid
trifluoroacetate (19).21f Using the general procedure above gave
(2S,5E)-2-amino-6-(40-bromophenyl)-4-oxohex-5-enoic acid tri-
fluoroacetate (19) as a white solid (0.14 g, 93%). Mp 151e152 ꢁC
D
t
(400 MHz, CDCl3) 1.44 (9H, s, Bu), 2.46e2.63 (2H, m, 7-H2), 2.79
(2H, t, J 7.7 Hz, 8-H2), 3.06 (1H, dd, J 18.0, 4.0 Hz, 3-HH), 3.30 (1H, dd,
J 18.0, 4.0 Hz, 3-HH), 3.73 (3H, s, OMe), 4.42e4.64 (1H, m, 2-H), 5.53
(1H, br d, J 8.8 Hz, NH), 6.10 (1H, dt, J 16.0,1.4 Hz, 5-H), 6.88 (1H, dt, J
16.0, 6.8 Hz, 6-H), 7.11e7.37 (5H, m, ArH); dC (101 MHz, CDCl3) 28.3
(CH3), 34.2 (CH2), 34.3 (CH2), 41.8 (CH2), 49.5 (CH), 52.6 (CH3), 79.9
(C), 126.3 (CH), 128.3 (2ꢂCH), 128.6 (2ꢂCH), 130.3 (CH), 140.5 (C),
147.8 (CH), 155.6 (C), 172.0 (C), 197.7 (C); m/z (FAB) 362 (MHþ, 14%),
306 (94), 262 (100), 203 (11), 176 (14), 160 (34), 93 (35), 90 (32);
HRMS (FAB): MHþ, found 362.1974. C20H28NO5 requires 362.1967.
(decomposition); nmax (neat) 3364 (NH), 3061, 1684 (C]O), 1607
(C]C), 1547, 1487, 1397, 1339 cmꢀ1; [
a]
þ55.0 (c 0.3, MeOH); dH
18
D
(400 MHz, CD3OD) 3.23 (1H, dd, J 18.8, 9.3 Hz, 3-HH), 3.46 (1H, dd, J
18.8, 3.4 Hz, 3-HH), 3.95 (1H, dd, J 9.3, 3.4 Hz, 2-H), 6.91 (1H, d, J
16.3 Hz, 5-H), 7.56e7.62 (4H, m, ArH), 7.67 (1H, d, J 16.3 Hz, 6-H); dC
(101 MHz, CD3OD) 40.9 (CH2), 50.2 (CH), 126.2 (C), 126.7 (CH), 131.3
(2ꢂCH), 133.4 (2ꢂCH), 134.8 (C), 144.6 (CH), 171.5 (C), 197.7 (C); m/z
(FAB) 298 (MHþ, 31%), 292 (16), 254 (12), 243 (21), 209 (18), 155
(29), 138 (15); HRMS (FAB): MHþ, found 298.0067. C12H1379BrNO3
requires 298.0079.
4.14. (2S,5E)-2-Amino-4-oxo-6-phenylhex-5-enoic acid hy-
drochloride (17)
To a solution of methyl (2S,5E)-2-(tert-butoxycarbonylamino)-
4-oxo-6-phenylhex-5-enoate (14) (0.20 g, 0.60 mmol) in methanol
(3.0 mL) was added 6.0 M hydrochloric acid (15 mL) and the re-
action mixture heated under reflux for 24 h. The mixture was
allowed to cool to room temperature and then extracted with
diethyl ether (2ꢂ20 mL). The aqueous layer was concentrated in
vacuo to give a yellow solid. Recrystallisation from chloroform and
methanol gave (2S,5E)-2-amino-4-oxo-6-phenylhex-5-enoic acid
hydrochloride (17) as an off-white solid (0.095 g, 62%). Mp
4.15.3. (2S,5E)-2-Amino-4-oxo-8-phenyloct-5-enoic
acid
tri-
fluoroacetate (20).21f The general two-step procedure described
above was used except that a 1:1 acetonitrile/water solution was
used for the hydrolysis step. This gave (2S,5E)-2-amino-4-oxo-8-
phenyloct-5-enoic acid trifluoroacetate (20) as a white solid
(0.10 g, 98%). Mp 94e96 ꢁC (decomposition); nmax (neat) 3161 (NH),
3030, 2918 (CH), 1736 (C]O), 1661 (C]C), 1640, 1604, 1497,
18
1180 cmꢀ1; [
a]
þ10.2 (c 0.3, MeOH); dH (400 MHz, CD3OD)
D
2.54e2.63 (2H, m, 7-H2), 2.82 (2H, t, J 7.4 Hz, 8-H2), 3.20 (1H, dd, J
18.8, 8.0 Hz, 3-HH), 3.28e3.37 (1H, m, 3-HH), 4.11 (1H, dd, J 8.0,
3.6 Hz, 2-H), 6.17 (1H, dt, J 16.0, 1.4 Hz, 5-H), 7.03 (1H, dt, J 16.0,
6.9 Hz, 6-H), 7.12e7.31 (5H, m, ArH); dC (101 MHz, CD3OD) 35.3
(CH2), 35.5 (CH2), 40.4 (CH2), 50.5 (CH), 127.3 (CH), 129.5 (2ꢂCH),
129.6 (2ꢂCH), 130.8 (CH), 142.1 (C), 150.5 (CH), 172.5 (C), 198.1 (C);
m/z (FAB) 248 (MHþ, 14%), 247 (2), 203 (8), 176 (12), 160 (8), 132 (4),
100 (1), 90 (3), 76 (4); HRMS (FAB): MHþ, found 248.1289.
151e153 ꢁC (decomposition); nmax (neat) 3058 (NH), 2976 (CH),
1736 (C]O), 1649 (C]C), 1174, 1126, 854 cmꢀ1; [
a]
þ35.8 (c 1.0,
24
D
MeOH); dH (400 MHz, CD3OD) 3.38e3.58 (2H, m, 3-H2), 4.36 (1H,
dd, J 6.6, 4.2 Hz, 2-H), 6.92 (1H, d, J 16.3 Hz, 5-H), 7.38e7.50 (3H, m,
ArH), 7.63e7.71 (2H, m, ArH), 7.76 (1H, d, J 16.3 Hz, 6-H); dC
(101 MHz, CD3OD) 40.7 (CH2), 49.3 (CH), 126.0 (CH), 129.8 (2ꢂCH),
130.2 (2ꢂCH), 132.2 (CH), 135.6 (C), 146.2 (CH), 171.3 (C), 197.6 (C);
m/z (CI) 220 (MHþ, 84%), 205 (100), 203 (61), 159 (53), 147 (34), 113
(21), 97 (20), 81 (50), 69 (61); HRMS (CI): MHþ, found 220.0978.
C14H18NO3 requires 248.1287.
C
12H14NO3 requires 220.0974.
Acknowledgements
4.15. General procedure for the deprotection of enones 14, 15
and 16
The authors are grateful to the University of Glasgow (student-
ship to K.N.F.), Engineering and Physical Sciences Research Council
(EP/P503582/1) (studentship to L.S.F.) and Pfizer for financial
support.
To
a solution of N-Boc-protected amino methyl ester
(0.16 mmol) in 1:1 methanol/water (4 mL) was added caesium
carbonate (0.21 mmol). The resultant suspension was stirred at
room temperature for 48 h. The reaction mixture was concentrated
in vacuo and the residue was dissolved in water (10 mL) and
acidified to pH 1 with hydrochloric acid (1 M). The aqueous layer
was washed with dichloromethane (3ꢂ20 mL) and the combined
Supplementary data
Supplementary data associated with this article can be found in